HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS?
Despite the decline in cardiovascular mortality rate in recent decades due to the widespread use of antihypertensive, hypocholesterolemic and antiplatelet drugs, various manifestations of ischemic heart disease (IHD) retain one-third of the mortality pattern in individuals older than 35 years [1-3]....
Saved in:
Main Author: | E. P. PANCHENKO (Author) |
---|---|
Format: | Book |
Published: |
«REMEDIUM GROUP» Ltd.,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
e-Teaching in pediatric cardiology: A paradigm shift
by: Sunita Maheshwari, et al.
Published: (2015)
by: Sunita Maheshwari, et al.
Published: (2015)
Similar Items
-
Clinical education and training: Have we sufficiently shifted our paradigm
by: A Rhoda
Published: (2018) -
e-Teaching in pediatric cardiology: A paradigm shift
by: Sunita Maheshwari, et al.
Published: (2015) -
Trading in our Paradigm Shifts for a Staircase
by: Diane Powers Dirette Ph.D., OTL
Published: (2013) -
Carbetocin: Are we ready for a paradigm shift?
by: Anjeleena K Gupta
Published: (2023) -
Artificial intelligence in pediatric cardiology and cardiac surgery: Irrational hype or paradigm shift?
by: Anthony C Chang
Published: (2019)